 Alexander Kaizer
Concepts (412)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Research Design | 9 | 2022 | 928 | 1.520 |
Why?
| | Atrioventricular Block | 4 | 2022 | 37 | 1.250 |
Why?
| | Bayes Theorem | 10 | 2022 | 329 | 1.110 |
Why?
| | Heart Rate, Fetal | 2 | 2023 | 20 | 1.040 |
Why?
| | Long QT Syndrome | 2 | 2023 | 59 | 0.980 |
Why?
| | Models, Statistical | 3 | 2018 | 599 | 0.950 |
Why?
| | Gastroesophageal Reflux | 6 | 2023 | 234 | 0.940 |
Why?
| | Bariatric Surgery | 6 | 2020 | 161 | 0.840 |
Why?
| | Medical Futility | 1 | 2022 | 20 | 0.820 |
Why?
| | Weight Loss | 8 | 2023 | 642 | 0.810 |
Why?
| | Obesity, Morbid | 6 | 2020 | 197 | 0.810 |
Why?
| | Ritonavir | 1 | 2022 | 71 | 0.800 |
Why?
| | Neoplasms | 4 | 2023 | 2097 | 0.790 |
Why?
| | Tobacco Products | 2 | 2020 | 98 | 0.770 |
Why?
| | Lupus Erythematosus, Systemic | 2 | 2022 | 219 | 0.710 |
Why?
| | Neostigmine | 1 | 2020 | 4 | 0.700 |
Why?
| | Pediatric Obesity | 8 | 2020 | 488 | 0.680 |
Why?
| | Humans | 97 | 2024 | 114686 | 0.670 |
Why?
| | Esophageal Achalasia | 3 | 2023 | 25 | 0.630 |
Why?
| | Data Collection | 1 | 2021 | 620 | 0.630 |
Why?
| | Spinal Cord Stimulation | 3 | 2024 | 7 | 0.630 |
Why?
| | Biostatistics | 1 | 2018 | 15 | 0.600 |
Why?
| | Laryngopharyngeal Reflux | 3 | 2023 | 13 | 0.600 |
Why?
| | Therapeutics | 1 | 2018 | 12 | 0.600 |
Why?
| | Anaphylaxis | 1 | 2020 | 143 | 0.570 |
Why?
| | Esophageal Motility Disorders | 3 | 2023 | 23 | 0.560 |
Why?
| | Clinical Protocols | 1 | 2018 | 233 | 0.540 |
Why?
| | Fetal Diseases | 4 | 2023 | 147 | 0.540 |
Why?
| | Data Interpretation, Statistical | 1 | 2018 | 321 | 0.530 |
Why?
| | Antibodies, Antinuclear | 3 | 2022 | 58 | 0.520 |
Why?
| | Retrospective Studies | 28 | 2024 | 12550 | 0.510 |
Why?
| | Tobacco Use Disorder | 1 | 2018 | 234 | 0.510 |
Why?
| | Ixodidae | 1 | 2015 | 5 | 0.500 |
Why?
| | Mucopolysaccharidosis I | 3 | 2019 | 9 | 0.470 |
Why?
| | Manometry | 7 | 2023 | 89 | 0.470 |
Why?
| | Larva | 1 | 2015 | 194 | 0.460 |
Why?
| | Prospective Studies | 19 | 2023 | 6220 | 0.460 |
Why?
| | Pepsin A | 3 | 2023 | 18 | 0.450 |
Why?
| | Anti-Obesity Agents | 3 | 2019 | 45 | 0.420 |
Why?
| | Esophagitis, Peptic | 2 | 2023 | 16 | 0.410 |
Why?
| | Analgesics, Opioid | 6 | 2022 | 771 | 0.400 |
Why?
| | Brachial Plexus Block | 2 | 2022 | 3 | 0.400 |
Why?
| | Esophageal pH Monitoring | 5 | 2023 | 23 | 0.400 |
Why?
| | Obesity | 5 | 2023 | 2508 | 0.400 |
Why?
| | Proton Pump Inhibitors | 6 | 2023 | 96 | 0.390 |
Why?
| | Treatment Outcome | 15 | 2023 | 9088 | 0.370 |
Why?
| | Anesthetics | 2 | 2022 | 54 | 0.370 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2022 | 1214 | 0.360 |
Why?
| | Nerve Block | 3 | 2021 | 60 | 0.360 |
Why?
| | Female | 42 | 2023 | 59507 | 0.350 |
Why?
| | Analgesia, Epidural | 2 | 2021 | 20 | 0.340 |
Why?
| | Body Contouring | 2 | 2020 | 8 | 0.340 |
Why?
| | Enzyme Replacement Therapy | 2 | 2019 | 10 | 0.340 |
Why?
| | Injections, Spinal | 2 | 2019 | 101 | 0.330 |
Why?
| | Pregnancy | 8 | 2023 | 5518 | 0.310 |
Why?
| | Adult | 25 | 2024 | 30550 | 0.300 |
Why?
| | Esophagus | 2 | 2020 | 225 | 0.300 |
Why?
| | Pain, Postoperative | 5 | 2022 | 191 | 0.300 |
Why?
| | Surgeons | 2 | 2021 | 239 | 0.290 |
Why?
| | Probability | 3 | 2022 | 289 | 0.280 |
Why?
| | Anesthetics, Local | 3 | 2022 | 81 | 0.270 |
Why?
| | Nicotine | 2 | 2020 | 265 | 0.270 |
Why?
| | Child | 17 | 2023 | 18414 | 0.250 |
Why?
| | Male | 34 | 2023 | 55596 | 0.250 |
Why?
| | Pregnancy Outcome | 3 | 2023 | 337 | 0.250 |
Why?
| | Bupivacaine | 2 | 2022 | 31 | 0.240 |
Why?
| | Incidence | 6 | 2023 | 2313 | 0.240 |
Why?
| | Hearing Aids | 2 | 2023 | 69 | 0.240 |
Why?
| | Laparoscopy | 2 | 2020 | 398 | 0.240 |
Why?
| | Body Weight | 2 | 2019 | 869 | 0.230 |
Why?
| | Adrenergic beta-Antagonists | 2 | 2023 | 287 | 0.230 |
Why?
| | Intraoperative Neurophysiological Monitoring | 1 | 2024 | 15 | 0.230 |
Why?
| | Hearing Loss, Sudden | 1 | 2023 | 8 | 0.220 |
Why?
| | Myotomy | 1 | 2023 | 8 | 0.220 |
Why?
| | Atrial Flutter | 1 | 2023 | 25 | 0.220 |
Why?
| | Sample Size | 2 | 2021 | 112 | 0.220 |
Why?
| | Tachycardia, Supraventricular | 1 | 2023 | 42 | 0.210 |
Why?
| | Intrauterine Devices, Medicated | 1 | 2023 | 23 | 0.210 |
Why?
| | Intestinal Atresia | 1 | 2023 | 16 | 0.210 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2023 | 60 | 0.210 |
Why?
| | Lopinavir | 1 | 2022 | 29 | 0.210 |
Why?
| | Postoperative Complications | 4 | 2021 | 2128 | 0.210 |
Why?
| | Lidocaine | 1 | 2023 | 40 | 0.210 |
Why?
| | Fetal Heart | 2 | 2019 | 37 | 0.210 |
Why?
| | Immunosorbents | 1 | 2022 | 1 | 0.200 |
Why?
| | Neutropenia | 1 | 2023 | 125 | 0.200 |
Why?
| | Telemedicine | 2 | 2021 | 662 | 0.200 |
Why?
| | Hepatectomy | 1 | 2023 | 119 | 0.200 |
Why?
| | Current Procedural Terminology | 1 | 2022 | 11 | 0.200 |
Why?
| | Tremor | 1 | 2022 | 45 | 0.200 |
Why?
| | Adolescent | 17 | 2023 | 17844 | 0.200 |
Why?
| | Diaphragm | 2 | 2022 | 33 | 0.200 |
Why?
| | Tympanoplasty | 1 | 2022 | 7 | 0.200 |
Why?
| | Tympanic Membrane Perforation | 1 | 2022 | 12 | 0.200 |
Why?
| | Deafness | 1 | 2023 | 78 | 0.190 |
Why?
| | Hydroxychloroquine | 1 | 2022 | 54 | 0.190 |
Why?
| | Enterocolitis, Neutropenic | 1 | 2021 | 6 | 0.190 |
Why?
| | Funnel Chest | 1 | 2021 | 22 | 0.190 |
Why?
| | Multiple Pulmonary Nodules | 1 | 2021 | 22 | 0.190 |
Why?
| | Epidermolysis Bullosa | 1 | 2022 | 41 | 0.190 |
Why?
| | Fetus | 2 | 2023 | 700 | 0.190 |
Why?
| | Infant, Newborn | 5 | 2023 | 5047 | 0.190 |
Why?
| | Carcinoma, Transitional Cell | 1 | 2022 | 53 | 0.190 |
Why?
| | Psychological Trauma | 1 | 2022 | 54 | 0.190 |
Why?
| | Paranasal Sinus Neoplasms | 1 | 2021 | 17 | 0.190 |
Why?
| | Nose Neoplasms | 1 | 2021 | 15 | 0.190 |
Why?
| | Patient Handoff | 1 | 2021 | 26 | 0.190 |
Why?
| | Tumor Burden | 1 | 2022 | 259 | 0.190 |
Why?
| | Disabled Persons | 1 | 2023 | 134 | 0.190 |
Why?
| | Prostate | 1 | 2022 | 156 | 0.190 |
Why?
| | Eructation | 1 | 2021 | 2 | 0.190 |
Why?
| | Hernia, Hiatal | 1 | 2021 | 31 | 0.190 |
Why?
| | Prenatal Diagnosis | 2 | 2019 | 167 | 0.180 |
Why?
| | Computer Simulation | 3 | 2022 | 873 | 0.180 |
Why?
| | Congenital Microtia | 1 | 2020 | 4 | 0.180 |
Why?
| | Cardiovascular Diseases | 3 | 2023 | 1727 | 0.180 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2023 | 222 | 0.180 |
Why?
| | Prevalence | 3 | 2023 | 2251 | 0.180 |
Why?
| | Medicare Part D | 1 | 2021 | 26 | 0.180 |
Why?
| | Pregnant Women | 1 | 2022 | 131 | 0.180 |
Why?
| | Spinal Cord Injuries | 1 | 2024 | 174 | 0.180 |
Why?
| | Specialties, Surgical | 1 | 2022 | 70 | 0.180 |
Why?
| | Cystectomy | 1 | 2021 | 32 | 0.180 |
Why?
| | Exercise | 3 | 2020 | 1644 | 0.180 |
Why?
| | Ear | 1 | 2020 | 32 | 0.180 |
Why?
| | Bias | 1 | 2021 | 179 | 0.180 |
Why?
| | Electrocardiography | 1 | 2023 | 560 | 0.180 |
Why?
| | Predictive Value of Tests | 2 | 2022 | 1796 | 0.180 |
Why?
| | Drug Costs | 1 | 2021 | 92 | 0.180 |
Why?
| | Ocular Hypertension | 1 | 2021 | 61 | 0.180 |
Why?
| | Substance Abuse Detection | 1 | 2021 | 62 | 0.180 |
Why?
| | Information Dissemination | 1 | 2022 | 186 | 0.180 |
Why?
| | Anesthesia | 1 | 2022 | 117 | 0.170 |
Why?
| | Shock | 1 | 2021 | 84 | 0.170 |
Why?
| | Congenital Abnormalities | 1 | 2020 | 73 | 0.170 |
Why?
| | Carcinoma | 1 | 2021 | 198 | 0.170 |
Why?
| | Heart Arrest | 1 | 2023 | 292 | 0.170 |
Why?
| | Hearing Loss | 1 | 2023 | 183 | 0.170 |
Why?
| | Parenteral Nutrition | 1 | 2021 | 96 | 0.170 |
Why?
| | Magnetocardiography | 1 | 2019 | 2 | 0.170 |
Why?
| | Tracheostomy | 1 | 2021 | 101 | 0.170 |
Why?
| | Glaucoma, Open-Angle | 1 | 2021 | 95 | 0.170 |
Why?
| | Speech Perception | 1 | 2021 | 79 | 0.170 |
Why?
| | Enteral Nutrition | 1 | 2021 | 160 | 0.160 |
Why?
| | Hyperplasia | 1 | 2020 | 163 | 0.160 |
Why?
| | Spine | 1 | 2021 | 136 | 0.160 |
Why?
| | Infant | 5 | 2023 | 7963 | 0.160 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2022 | 196 | 0.160 |
Why?
| | Cochlear Implantation | 1 | 2021 | 80 | 0.160 |
Why?
| | Perioperative Care | 1 | 2020 | 127 | 0.160 |
Why?
| | Cochlear Implants | 1 | 2021 | 94 | 0.160 |
Why?
| | Stillbirth | 1 | 2019 | 57 | 0.160 |
Why?
| | Drug Prescriptions | 1 | 2021 | 239 | 0.160 |
Why?
| | Intra-Abdominal Fat | 1 | 2019 | 77 | 0.160 |
Why?
| | Medically Underserved Area | 1 | 2019 | 80 | 0.160 |
Why?
| | Aged | 12 | 2024 | 19074 | 0.160 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2023 | 288 | 0.160 |
Why?
| | Depressive Disorder, Major | 1 | 2022 | 301 | 0.160 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2019 | 54 | 0.160 |
Why?
| | Body Weight Maintenance | 1 | 2019 | 15 | 0.160 |
Why?
| | Outpatients | 1 | 2022 | 326 | 0.160 |
Why?
| | Cardiotocography | 1 | 2018 | 3 | 0.160 |
Why?
| | Cell-Derived Microparticles | 1 | 2019 | 57 | 0.160 |
Why?
| | Abortion, Spontaneous | 1 | 2019 | 90 | 0.160 |
Why?
| | Home Care Services, Hospital-Based | 1 | 2018 | 10 | 0.160 |
Why?
| | Cannabinoids | 1 | 2020 | 115 | 0.160 |
Why?
| | Body Mass Index | 4 | 2023 | 1959 | 0.160 |
Why?
| | Nutritional Status | 1 | 2021 | 287 | 0.160 |
Why?
| | Phenotype | 2 | 2023 | 2796 | 0.160 |
Why?
| | Genotype | 1 | 2023 | 1760 | 0.160 |
Why?
| | Soaps | 1 | 2018 | 10 | 0.150 |
Why?
| | Baths | 1 | 2018 | 17 | 0.150 |
Why?
| | Postoperative Nausea and Vomiting | 1 | 2018 | 10 | 0.150 |
Why?
| | Pain Management | 1 | 2021 | 288 | 0.150 |
Why?
| | Gastroenterology | 1 | 2020 | 159 | 0.150 |
Why?
| | Glaucoma | 1 | 2021 | 202 | 0.150 |
Why?
| | Anti-Infective Agents, Local | 1 | 2018 | 40 | 0.150 |
Why?
| | Adaptive Clinical Trials as Topic | 1 | 2018 | 19 | 0.150 |
Why?
| | Africa, Western | 1 | 2018 | 16 | 0.150 |
Why?
| | Ultrasonography, Prenatal | 1 | 2019 | 236 | 0.150 |
Why?
| | Parkinson Disease | 1 | 2022 | 345 | 0.150 |
Why?
| | Risk Factors | 9 | 2023 | 8632 | 0.150 |
Why?
| | Middle Aged | 13 | 2023 | 26737 | 0.150 |
Why?
| | Ovarian Neoplasms | 1 | 2022 | 388 | 0.150 |
Why?
| | Hemorrhagic Fever, Ebola | 1 | 2018 | 33 | 0.150 |
Why?
| | Barrett Esophagus | 1 | 2020 | 147 | 0.150 |
Why?
| | Burns | 1 | 2021 | 237 | 0.140 |
Why?
| | Thoracic Surgery, Video-Assisted | 1 | 2017 | 40 | 0.140 |
Why?
| | Dyslipidemias | 1 | 2019 | 154 | 0.140 |
Why?
| | Respiration, Artificial | 1 | 2021 | 529 | 0.140 |
Why?
| | Penicillin Resistance | 1 | 2017 | 8 | 0.140 |
Why?
| | Serogroup | 1 | 2017 | 26 | 0.140 |
Why?
| | Disinfection | 1 | 2018 | 106 | 0.140 |
Why?
| | Child Behavior | 1 | 2019 | 219 | 0.140 |
Why?
| | Pancreaticoduodenectomy | 1 | 2018 | 133 | 0.140 |
Why?
| | United States | 9 | 2024 | 12183 | 0.140 |
Why?
| | Echocardiography | 1 | 2019 | 553 | 0.140 |
Why?
| | Phentermine | 1 | 2016 | 8 | 0.140 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2019 | 152 | 0.140 |
Why?
| | Cigarette Smoking | 1 | 2018 | 74 | 0.140 |
Why?
| | Blood Platelets | 1 | 2019 | 351 | 0.140 |
Why?
| | Antiviral Agents | 1 | 2022 | 645 | 0.130 |
Why?
| | Gestational Age | 4 | 2019 | 760 | 0.130 |
Why?
| | Mentoring | 1 | 2018 | 100 | 0.130 |
Why?
| | Disease Models, Animal | 2 | 2023 | 3535 | 0.130 |
Why?
| | Pneumonectomy | 1 | 2017 | 125 | 0.130 |
Why?
| | Suicide | 1 | 2022 | 506 | 0.130 |
Why?
| | Fructose | 1 | 2016 | 100 | 0.130 |
Why?
| | Internal Medicine | 1 | 2018 | 211 | 0.130 |
Why?
| | Heart-Assist Devices | 1 | 2022 | 485 | 0.130 |
Why?
| | Spinal Cord | 3 | 2024 | 347 | 0.130 |
Why?
| | Anti-Bacterial Agents | 2 | 2023 | 1481 | 0.130 |
Why?
| | Reproducibility of Results | 5 | 2021 | 2764 | 0.130 |
Why?
| | Pneumococcal Infections | 1 | 2017 | 91 | 0.130 |
Why?
| | Heart Transplantation | 1 | 2022 | 665 | 0.130 |
Why?
| | Body Composition | 1 | 2019 | 590 | 0.130 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 191 | 0.130 |
Why?
| | Cross-Sectional Studies | 6 | 2023 | 4409 | 0.130 |
Why?
| | Faculty, Medical | 1 | 2018 | 228 | 0.130 |
Why?
| | Length of Stay | 4 | 2021 | 962 | 0.130 |
Why?
| | Critical Illness | 1 | 2021 | 646 | 0.130 |
Why?
| | Streptococcus pneumoniae | 1 | 2017 | 133 | 0.130 |
Why?
| | Adiposity | 2 | 2019 | 458 | 0.130 |
Why?
| | Surgical Wound Infection | 1 | 2018 | 248 | 0.130 |
Why?
| | Surveys and Questionnaires | 3 | 2022 | 4623 | 0.130 |
Why?
| | Aortic Valve Stenosis | 1 | 2019 | 272 | 0.130 |
Why?
| | Cognitive Dysfunction | 1 | 2019 | 284 | 0.120 |
Why?
| | Precision Medicine | 1 | 2019 | 337 | 0.120 |
Why?
| | Lung Diseases | 1 | 2022 | 701 | 0.120 |
Why?
| | Missouri | 1 | 2015 | 61 | 0.120 |
Why?
| | Meals | 1 | 2016 | 104 | 0.120 |
Why?
| | Hematopoietic Stem Cell Transplantation | 2 | 2019 | 520 | 0.120 |
Why?
| | Disease Outbreaks | 1 | 2018 | 307 | 0.120 |
Why?
| | Pilot Projects | 4 | 2021 | 1373 | 0.120 |
Why?
| | Forests | 1 | 2015 | 48 | 0.120 |
Why?
| | Veterans | 2 | 2022 | 1249 | 0.120 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2022 | 758 | 0.120 |
Why?
| | Hypertension | 1 | 2022 | 1056 | 0.120 |
Why?
| | Wounds and Injuries | 1 | 2022 | 749 | 0.120 |
Why?
| | Hypoxia | 1 | 2020 | 958 | 0.110 |
Why?
| | Pregnancy Complications | 1 | 2018 | 429 | 0.110 |
Why?
| | Opioid-Related Disorders | 1 | 2021 | 413 | 0.110 |
Why?
| | Cannabis | 1 | 2020 | 384 | 0.110 |
Why?
| | Clinical Competence | 1 | 2020 | 893 | 0.110 |
Why?
| | Mothers | 1 | 2019 | 651 | 0.110 |
Why?
| | Feeding Behavior | 1 | 2019 | 574 | 0.110 |
Why?
| | Medicare | 3 | 2024 | 665 | 0.110 |
Why?
| | Endothelium, Vascular | 1 | 2019 | 847 | 0.110 |
Why?
| | Hospitalization | 1 | 2022 | 1752 | 0.110 |
Why?
| | Heart Defects, Congenital | 1 | 2019 | 671 | 0.110 |
Why?
| | Physicians | 1 | 2021 | 772 | 0.110 |
Why?
| | Esophagogastric Junction | 2 | 2023 | 42 | 0.110 |
Why?
| | Seasons | 1 | 2015 | 442 | 0.100 |
Why?
| | Muscle Spasticity | 2 | 2023 | 53 | 0.100 |
Why?
| | Intensive Care Units | 3 | 2021 | 617 | 0.100 |
Why?
| | Minnesota | 3 | 2018 | 134 | 0.100 |
Why?
| | Lung | 2 | 2022 | 3561 | 0.100 |
Why?
| | Mental Health | 1 | 2018 | 562 | 0.100 |
Why?
| | Internship and Residency | 1 | 2022 | 926 | 0.100 |
Why?
| | Cognition | 1 | 2019 | 989 | 0.100 |
Why?
| | Insulin Resistance | 1 | 2020 | 1072 | 0.100 |
Why?
| | Electric Impedance | 2 | 2023 | 100 | 0.100 |
Why?
| | Animals | 4 | 2023 | 31706 | 0.100 |
Why?
| | Anxiety | 1 | 2018 | 840 | 0.100 |
Why?
| | Heartburn | 2 | 2021 | 11 | 0.090 |
Why?
| | Antineoplastic Agents | 1 | 2022 | 1879 | 0.090 |
Why?
| | Monitoring, Ambulatory | 2 | 2023 | 81 | 0.090 |
Why?
| | Cohort Studies | 4 | 2021 | 4895 | 0.090 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2023 | 511 | 0.090 |
Why?
| | Operating Rooms | 2 | 2022 | 86 | 0.090 |
Why?
| | Saliva | 2 | 2023 | 187 | 0.090 |
Why?
| | Ecosystem | 1 | 2015 | 502 | 0.090 |
Why?
| | Swine | 2 | 2023 | 700 | 0.090 |
Why?
| | Medical Oncology | 2 | 2022 | 229 | 0.090 |
Why?
| | Depression | 1 | 2018 | 1134 | 0.090 |
Why?
| | Cesarean Section | 2 | 2023 | 169 | 0.090 |
Why?
| | Operative Time | 2 | 2022 | 106 | 0.080 |
Why?
| | Time Factors | 4 | 2022 | 6115 | 0.080 |
Why?
| | Prognosis | 3 | 2023 | 3329 | 0.080 |
Why?
| | Tertiary Care Centers | 2 | 2022 | 126 | 0.080 |
Why?
| | Lung Neoplasms | 1 | 2021 | 2177 | 0.080 |
Why?
| | Ultrasonography, Interventional | 2 | 2021 | 123 | 0.080 |
Why?
| | Child, Preschool | 5 | 2021 | 9116 | 0.080 |
Why?
| | Sensitivity and Specificity | 2 | 2023 | 1692 | 0.070 |
Why?
| | Pain Measurement | 2 | 2022 | 444 | 0.070 |
Why?
| | Feasibility Studies | 2 | 2022 | 740 | 0.070 |
Why?
| | Follow-Up Studies | 3 | 2021 | 4411 | 0.070 |
Why?
| | Mice | 1 | 2022 | 14869 | 0.070 |
Why?
| | Caregivers | 2 | 2023 | 717 | 0.060 |
Why?
| | Anesthesia, General | 1 | 2024 | 44 | 0.060 |
Why?
| | Hydrops Fetalis | 1 | 2023 | 13 | 0.060 |
Why?
| | Digoxin | 1 | 2023 | 26 | 0.060 |
Why?
| | Case-Control Studies | 2 | 2021 | 3003 | 0.060 |
Why?
| | Pandemics | 2 | 2022 | 1317 | 0.050 |
Why?
| | Esophageal Sphincter, Lower | 1 | 2023 | 10 | 0.050 |
Why?
| | Tachycardia | 1 | 2023 | 50 | 0.050 |
Why?
| | Longitudinal Studies | 2 | 2020 | 2387 | 0.050 |
Why?
| | Anti-Arrhythmia Agents | 1 | 2023 | 106 | 0.050 |
Why?
| | Edema | 1 | 2023 | 119 | 0.050 |
Why?
| | Epinephrine | 1 | 2023 | 163 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 2 | 2022 | 2286 | 0.050 |
Why?
| | Fingers | 1 | 2022 | 83 | 0.050 |
Why?
| | Goals | 1 | 2023 | 147 | 0.050 |
Why?
| | Motor Skills | 1 | 2022 | 82 | 0.050 |
Why?
| | Rotator Cuff | 1 | 2022 | 43 | 0.050 |
Why?
| | False Positive Reactions | 1 | 2022 | 109 | 0.050 |
Why?
| | Esophageal Sphincter, Upper | 1 | 2021 | 5 | 0.050 |
Why?
| | Patients | 1 | 2023 | 163 | 0.050 |
Why?
| | Meta-Analysis as Topic | 1 | 2022 | 158 | 0.050 |
Why?
| | Proton Pumps | 1 | 2021 | 8 | 0.050 |
Why?
| | Personal Satisfaction | 1 | 2023 | 182 | 0.050 |
Why?
| | Malawi | 1 | 2021 | 48 | 0.050 |
Why?
| | Cluster Analysis | 1 | 2022 | 455 | 0.050 |
Why?
| | Prostheses and Implants | 1 | 2022 | 137 | 0.050 |
Why?
| | Tonometry, Ocular | 1 | 2021 | 83 | 0.050 |
Why?
| | Accidental Falls | 1 | 2023 | 151 | 0.050 |
Why?
| | Hearing Loss, Conductive | 1 | 2020 | 22 | 0.050 |
Why?
| | Risk Assessment | 2 | 2020 | 2968 | 0.040 |
Why?
| | Benchmarking | 1 | 2022 | 161 | 0.040 |
Why?
| | Biomarkers | 2 | 2021 | 3408 | 0.040 |
Why?
| | Gastrointestinal Agents | 1 | 2021 | 60 | 0.040 |
Why?
| | Iron | 1 | 2022 | 233 | 0.040 |
Why?
| | Cough | 1 | 2021 | 107 | 0.040 |
Why?
| | Developmental Disabilities | 1 | 2023 | 237 | 0.040 |
Why?
| | Fitness Trackers | 1 | 2020 | 8 | 0.040 |
Why?
| | Noise | 1 | 2021 | 68 | 0.040 |
Why?
| | ROC Curve | 1 | 2021 | 442 | 0.040 |
Why?
| | United Arab Emirates | 1 | 2020 | 5 | 0.040 |
Why?
| | Reoperation | 1 | 2022 | 514 | 0.040 |
Why?
| | Iduronidase | 1 | 2019 | 2 | 0.040 |
Why?
| | Los Angeles | 1 | 2020 | 56 | 0.040 |
Why?
| | Competency-Based Education | 1 | 2020 | 65 | 0.040 |
Why?
| | Ultrasonography, Doppler, Pulsed | 1 | 2019 | 6 | 0.040 |
Why?
| | Waist Circumference | 1 | 2020 | 122 | 0.040 |
Why?
| | Colorado | 2 | 2019 | 4099 | 0.040 |
Why?
| | Abdominoplasty | 1 | 2019 | 6 | 0.040 |
Why?
| | Piperidines | 1 | 2021 | 160 | 0.040 |
Why?
| | Fundoplication | 1 | 2020 | 53 | 0.040 |
Why?
| | Collagen | 1 | 2022 | 415 | 0.040 |
Why?
| | Dermatologic Surgical Procedures | 1 | 2019 | 19 | 0.040 |
Why?
| | Trauma Centers | 1 | 2022 | 362 | 0.040 |
Why?
| | Blood Transfusion | 1 | 2022 | 293 | 0.040 |
Why?
| | Fathers | 1 | 2019 | 45 | 0.040 |
Why?
| | Biomarkers, Pharmacological | 1 | 2019 | 26 | 0.040 |
Why?
| | Glucocorticoids | 1 | 2023 | 532 | 0.040 |
Why?
| | Intraocular Pressure | 1 | 2021 | 276 | 0.040 |
Why?
| | Hemodynamics | 1 | 2023 | 1012 | 0.040 |
Why?
| | Analgesics | 1 | 2020 | 158 | 0.040 |
Why?
| | Glycosaminoglycans | 1 | 2019 | 79 | 0.040 |
Why?
| | Heterozygote | 1 | 2019 | 251 | 0.040 |
Why?
| | Mupirocin | 1 | 2018 | 7 | 0.040 |
Why?
| | Endoscopy, Digestive System | 1 | 2020 | 110 | 0.040 |
Why?
| | Mouthwashes | 1 | 2018 | 12 | 0.040 |
Why?
| | Young Adult | 3 | 2019 | 10469 | 0.040 |
Why?
| | Patient Care Bundles | 1 | 2018 | 17 | 0.040 |
Why?
| | Drug Administration Schedule | 1 | 2020 | 718 | 0.040 |
Why?
| | Staff Development | 1 | 2018 | 39 | 0.040 |
Why?
| | Mortality | 1 | 2020 | 287 | 0.040 |
Why?
| | Guidelines as Topic | 1 | 2020 | 243 | 0.040 |
Why?
| | Chlorhexidine | 1 | 2018 | 22 | 0.040 |
Why?
| | Administration, Intranasal | 1 | 2018 | 75 | 0.040 |
Why?
| | Precancerous Conditions | 1 | 2020 | 158 | 0.040 |
Why?
| | Superficial Back Muscles | 1 | 2018 | 13 | 0.040 |
Why?
| | Nasal Cavity | 1 | 2018 | 47 | 0.040 |
Why?
| | Catheters | 1 | 2018 | 63 | 0.040 |
Why?
| | Self Administration | 1 | 2018 | 122 | 0.040 |
Why?
| | Carrier State | 1 | 2018 | 54 | 0.040 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2020 | 203 | 0.040 |
Why?
| | Comorbidity | 1 | 2022 | 1448 | 0.040 |
Why?
| | Patient Satisfaction | 1 | 2021 | 578 | 0.040 |
Why?
| | Fellowships and Scholarships | 1 | 2020 | 227 | 0.040 |
Why?
| | Endoscopy | 1 | 2020 | 246 | 0.040 |
Why?
| | Time-to-Treatment | 1 | 2018 | 147 | 0.040 |
Why?
| | Arrhythmias, Cardiac | 1 | 2019 | 279 | 0.040 |
Why?
| | Postoperative Period | 1 | 2018 | 289 | 0.040 |
Why?
| | Hospital Mortality | 1 | 2021 | 776 | 0.030 |
Why?
| | Lipoproteins, VLDL | 1 | 2016 | 21 | 0.030 |
Why?
| | Africa | 1 | 2017 | 94 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2019 | 544 | 0.030 |
Why?
| | Risk | 1 | 2019 | 812 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2020 | 1078 | 0.030 |
Why?
| | Body Constitution | 1 | 2016 | 47 | 0.030 |
Why?
| | Birth Weight | 1 | 2019 | 440 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2019 | 1230 | 0.030 |
Why?
| | Diet, Reducing | 1 | 2016 | 76 | 0.030 |
Why?
| | Preoperative Care | 1 | 2018 | 319 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2023 | 833 | 0.030 |
Why?
| | Premature Birth | 1 | 2019 | 276 | 0.030 |
Why?
| | Databases, Factual | 1 | 2020 | 1125 | 0.030 |
Why?
| | Absorptiometry, Photon | 1 | 2016 | 224 | 0.030 |
Why?
| | Education, Medical | 1 | 2018 | 215 | 0.030 |
Why?
| | Metabolic Diseases | 1 | 2016 | 98 | 0.030 |
Why?
| | Aortic Valve | 1 | 2019 | 398 | 0.030 |
Why?
| | Military Personnel | 1 | 2022 | 524 | 0.030 |
Why?
| | Survival Rate | 1 | 2019 | 1644 | 0.030 |
Why?
| | Liver | 1 | 2023 | 1637 | 0.030 |
Why?
| | Algorithms | 1 | 2022 | 1469 | 0.030 |
Why?
| | Risk Reduction Behavior | 1 | 2016 | 201 | 0.030 |
Why?
| | Fetal Growth Retardation | 1 | 2019 | 467 | 0.030 |
Why?
| | Behavior Therapy | 1 | 2016 | 226 | 0.030 |
Why?
| | Staphylococcal Infections | 1 | 2018 | 340 | 0.030 |
Why?
| | Quality Improvement | 1 | 2021 | 950 | 0.030 |
Why?
| | Registries | 1 | 2021 | 1768 | 0.030 |
Why?
| | Health Services Accessibility | 1 | 2019 | 763 | 0.030 |
Why?
| | Logistic Models | 1 | 2018 | 1841 | 0.030 |
Why?
| | Muscle, Skeletal | 1 | 2022 | 1473 | 0.030 |
Why?
| | Primary Health Care | 1 | 2023 | 1513 | 0.030 |
Why?
| | Disease Progression | 1 | 2020 | 2380 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2016 | 1660 | 0.030 |
Why?
| | Parents | 1 | 2019 | 1186 | 0.020 |
Why?
| | Insulin | 1 | 2020 | 2079 | 0.020 |
Why?
| | Diet | 1 | 2017 | 1080 | 0.020 |
Why?
|
|
Kaizer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|